News Scientific 'superintelligence' firm Lila launches with $200m Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances.
News Biogen, Apple study finds smart devices can track cognition An observational study backed by Biogen has suggested that Apple smartphones and watches may be able to spot the signs of mild cognitive impairment.
News Digital health firm XRHealth hits the M&A trial again XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare.
News Sofinnova raises €1.2bn to back 'up to 60' companies Sofinnova has raised €1.2bn that it says could support 50 to 60 companies across biotech, medtech, industrial biotech, and digital medicine.
News Pharma urges NHS to put medicines at heart of 10-year plan The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.
News FDA clears lifesaving feature for Google's Pixel Watch 3 The FDA has approved loss of pulse detection for Google's Pixel Watch 3, almost six months after the smartwatch was launched in the US.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.